Back to results
US 2026/0061013 A1Published application
Synthetic oncolytic lnp-replicon rna and uses for cancer immunotherapy
AssigneesMassachusetts Institute of Technology, Ohio State Innovation Foundation
InventorsDarrell J. Irvine, Karl Dane Wittrup, Ron Weiss, Yingzhong Li, Noor Momin, Yizhou Dong
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to synthetic oncolytic viruses comprising a lipid nanoparticle comprising one or more types of lipid and a self-amplifying replicon RNA comprising a sequence that encodes an immunomodulatory molecule.
Claims24
A synthetic oncolytic virus, comprising:
- (i) a lipid nanoparticle comprising one or more types of lipid;
- and
- (ii) a self-amplifying replicon RNA comprising a sequence that encodes an interleukin (IL)-12 molecule;
- wherein the lipid nanoparticle is capable of triggering immunogenic cell death, and
- wherein the IL-12 molecule is expressed by the self-amplifying replicon RNA.
2 more elements
(canceled)
-12. (canceled)
-17. (canceled)
(canceled)
Dependencies are inferred from the claim text.